1. Home
  2. RMTI

as 12-20-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.

Founded: 1994 Country:
United States
United States
Employees: N/A City: WIXOM
Market Cap: 72.7M IPO Year: 1998
Target Price: $6.00 AVG Volume (30 days): 660.2K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -0.05 EPS Growth: N/A
52 Week Low/High: $1.16 - $5.15 Next Earning Date: 11-12-2024
Revenue: $98,917,000 Revenue Growth: 22.37%
Revenue Growth (this year): 22.58% Revenue Growth (next year): -17.21%

RMTI Daily Stock ML Predictions

Stock Insider Trading Activity of Rockwell Medical Inc. (RMTI)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
RAVICH MARK H RMTI Director Nov 15 '24 Sell $2.36 29,991 $70,379.12 121,429
Strobeck Mark RMTI President and CEO Oct 1 '24 Sell $3.69 2,163 $7,971.09 147,201
Chole Timothy RMTI SVP, Chief Commercial Officer Oct 1 '24 Sell $3.69 1,001 $3,688.89 55,171

Share on Social Networks: